GPCRdb

ocaperidone

Agent/drug
Bioactivity

ocaperidone

SMILES	Cc1nc2c(C)cccn2c(=O)c1CCN1CCC(c2noc3cc(F)ccc23)CC1
InChIKey	ZZQNEJILGNNOEP-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors	6
Hydrogen bond donors	0
Rotatable bonds	4
Molecular weight (Da)	420.2

Database connections

PubChem Guide To Pharmacology ChEMBL_compound_ids DrugBank GPCRdb

Bioactivities

Affinity
Potency

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

5-HT_1A	5HT1A	Human	5-Hydroxytryptamine	A	pKi	8.00	8.00	8.00	Guide to Pharmacology
5-HT_1A	5HT1A	Human	5-Hydroxytryptamine	A	pKi	7.86	7.86	7.86	PDSP Ki database
5-HT_1D	5HT1D	Human	5-Hydroxytryptamine	A	pKi	8.70	8.75	8.80	Guide to Pharmacology
D₂	DRD2	Human	Dopamine	A	pKi	9.40	9.70	10.00	PDSP Ki database
D₃	DRD3	Human	Dopamine	A	pKi	8.54	8.84	9.15	PDSP Ki database
D₄	DRD4	Human	Dopamine	A	pKi	8.18	8.18	8.18	PDSP Ki database

Showing 1 to 6 of 6 entries

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

5-HT_1B	5HT1B	Human	5-Hydroxytryptamine	A	pIC50	6.90	7.05	7.20	Guide to Pharmacology

Showing 1 to 1 of 1 entry

ocaperidone

Drug properties

Molecular type	Small molecule
Physiological/Surrogate	Surrogate
Approved drug	Yes

Distribution across phases (no. indications)

Phase I 0

Phase II 0

Phase III 0

Phase IV

Database connections

PubChem Guide To Pharmacology ChEMBL_compound_ids DrugBank GPCRdb

Compound is not listed as a drug.